Receptor subtypes involved in relaxation and contraction by arginine vasopressin in canine isolated short posterior ciliary arteries

被引:26
作者
Okamura, T [1 ]
Toda, M [1 ]
Ayajiki, K [1 ]
Toda, N [1 ]
机构
[1] Shiga Univ Med Sci, Dept Pharmacol, Ohtsu, Shiga 52021, Japan
关键词
arginine vasopressin; ciliary artery; nitric oxide; vasopressin receptor subtype; endothelium;
D O I
10.1159/000159257
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Arginine vasopressin (AVP) produced relaxations at low concentrations(10(-11) and 10(-10) M) and contractions at higher concentrations in canine ciliary arterial strips with endothelium, partially contracted with prostglandin F-2 alpha. The AVP-induced relaxation was abolished or reversed to a contraction by removal of the endothelium or treatment with N-G-nitro-L-arginine. The effect of this antagonist was reversed by L-arginine. The relaxant response was inhibited dose-dependently by SR49059 (10(-10)-10(-9) M), [Pump(1),Tyr(Me)(2)]Arg(8)-vasopressin (PMP-AVP) (10(-10)-10(-9) M), V-1 receptor antagonists, and OPC31260 (3 x 10(-8) M), a reported V-2 receptor antagonist, but not by OPC21268 (10(-7)-10(-6) M), a reported V-1 antagonist. In the endothelium-denuded strips, the AVP-induced contraction was attenuated by SR49059, PMP-AVP and OPC31260, but not by OPC21268. It is concluded that AVP in low concentrations elicits intense relaxation of canine ciliary arteries, possibly due to nitric oxide synthesized in association with activation of the endothelial V-1 receptor subtype. AVP-induced contractions appear to be mediated also by the V-1 receptor in smooth muscle. Antagonistic selectivities of the OPC compounds to vasopressin receptor subtypes could not be seen in this particular material.
引用
收藏
页码:464 / 472
页数:9
相关论文
共 38 条
[31]  
TODA N, 1995, J PHARMACOL EXP THER, V274, P1507
[32]  
TODA N, 1992, J PHARMACOL EXP THER, V261, P234
[33]   POSSIBLE ROLE OF NITRIC-OXIDE IN TRANSMITTING INFORMATION FROM VASODILATOR NERVE TO CEREBROARTERIAL MUSCLE [J].
TODA, N ;
OKAMURA, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 170 (01) :308-313
[34]   IMPAIRMENT BY DAMAGE OF THE PTERYGOPALATINE GANGLION OF NITROXIDERGIC VASODILATOR NERVE FUNCTION IN CANINE CEREBRAL AND RETINAL ARTERIES [J].
TODA, N ;
AYAJIKI, K ;
YOSHIDA, K ;
KIMURA, H ;
OKAMURA, T .
CIRCULATION RESEARCH, 1993, 72 (01) :206-213
[35]  
WIENCKE AK, 1994, INVEST OPHTH VIS SCI, V35, P3268
[36]   OPC-21268, AN ORALLY EFFECTIVE, NONPEPTIDE VASOPRESSIN-VI RECEPTOR ANTAGONIST [J].
YAMAMURA, Y ;
OGAWA, H ;
CHIHARA, T ;
KONDO, K ;
ONOGAWA, T ;
NAKAMURA, S ;
MORI, T ;
TOMINAGA, M ;
YABUUCHI, Y .
SCIENCE, 1991, 252 (5005) :572-574
[37]   CHARACTERIZATION OF A NOVEL AQUARETIC AGENT, OPC-31260, AS AN ORALLY EFFECTIVE, NONPEPTIDE VASOPRESSIN V2-RECEPTOR ANTAGONIST [J].
YAMAMURA, Y ;
OGAWA, H ;
YAMASHITA, H ;
CHIHARA, T ;
MIYAMOTO, H ;
NAKAMURA, S ;
ONOGAWA, T ;
YAMASHITA, T ;
HOSOKAWA, T ;
MORI, T ;
TOMINAGA, M ;
YABUUCHI, Y .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (04) :787-791
[38]  
YAO K, 1991, INVEST OPHTH VIS SCI, V32, P1791